Active ingredient
Rifampin
20 finished FDA listings contain Rifampin as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- RIFAMPIN
- Dosage forms
- Capsule, Injection, Powder, Lyophilized, For Solution
- Routes
- Intravenous, Oral
- Manufacturers / labelers
- 14
- Strengths listed
- 150 mg/1 · 300 mg/1 · 600 mg/1 · 600 mg/10ml
- Brand names in FDA listings
- Rifadin Iv
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 9384
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 050627 | SANOFI AVENTIS US | 1989-05-25 | 1 |
| ANDA 064150 | EPIC PHARMA LLC | 1997-05-28 | 5 |
| ANDA 065390 | CHARTWELL MOLECULAR | 2008-03-28 | 2 |
| ANDA 065421 | MYLAN LABS LTD | 2008-05-22 | 1 |
| ANDA 090034 | LUPIN PHARMS | 2013-08-21 | 7 |
| ANDA 091181 | FRESENIUS KABI USA | 2014-08-21 | 1 |
| ANDA 205039 | HIKMA PHARMS | 2016-03-03 | 1 |
| ANDA 219918 | NOVITIUM PHARMA | 2026-06-29 | 2 |
Official labeling on DailyMed
- RIFAMPIN CAPSULE [ANI PHARMACEUTICALS, INC.] · version 1 · 2026-07-20
- RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC] · version 52 · 2026-05-29
- RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MYLAN INSTITUTIONAL LLC] · version 14 · 2026-05-21
- RIFAMPIN CAPSULE [BRYANT RANCH PREPACK] · version 100 · 2026-03-16
- RIFAMPIN CAPSULE [MAJOR PHARMACEUTICALS] · version 4 · 2026-03-12
- RIFAMPIN CAPSULE [LUPIN PHARMACEUTICALS, INC.] · version 26 · 2026-02-16
- RIFAMPIN CAPSULE [A-S MEDICATION SOLUTIONS] · version 7 · 2026-01-06
- RIFAMPIN CAPSULE [COUPLER LLC] · version 1 · 2025-11-17
- RIFAMPIN CAPSULE [PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS] · version 3 · 2025-03-27
- RIFAMPIN CAPSULE [EPIC PHARMA, LLC] · version 6 · 2023-12-21
- RIFAMPIN CAPSULE [CHARTWELL RX, LLC] · version 1 · 2023-04-17
- RIFAMPIN (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC · version 8 · 2022-10-13
Showing the 12 most recent of 13 labels.
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.